The sale of 23andMe has been finalized, transforming the once-public genetics company into a nonprofit under the leadership of its cofounder, Anne Wojcicki.  The deal—approved by U.S. Bankruptcy Judge Brian C. Walsh—marks the end of a months-long bidding war following 23andMe’s bankruptcy filing in March 2025. TTAM Outbids Regeneron in $305 Million Deal Biotech firm … Continue reading Privacy Concerns: 23andMe Restructures as Nonprofit with Acquisition by TTAM Research Institute